Merit Medical Systems, Inc. Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Million

Consolidate Quarterly Results

Jun'25

Mar'25

Dec'24

Sep'24

Jun'24

Mar'24

Dec'23

Net Sales

381.95

354.33

354.57

339.14

337.58

323.10

323.29

Other Operating Income

0.00

Total Operating income

381.95

354.33

354.57

339.14

337.58

323.10

323.29

Raw Material Cost

197.73

182.80

181.16

182.56

177.26

172.22

188.09

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

0.00

Power Cost

0.00

Manufacturing Expenses

6.78

6.57

7.99

7.76

8.38

8.75

5.68

Selling and Distribution Expenses

113.10

98.29

107.97

99.64

94.58

87.73

80.81

Other Expenses

1.76

1.59

1.72

1.28

1.19

1.27

1.60

Total Expenditure (Excl Depreciation)

335.20

303.56

314.33

302.74

292.11

281.43

290.53

Operating Profit (PBDIT) excl Other Income

46.8

50.8

40.199999999999996

36.4

45.5

41.7

32.8

Other Income

2.20

4.14

1.60

10.24

8.41

7.13

4.67

Operating Profit (PBDIT)

82.76

87.18

73.43

76.02

80.91

75.52

63.73

Interest

6.78

6.57

7.99

7.76

8.38

8.75

5.68

Exceptional Items

1.20

-10.38

-0.69

-2.23

0.34

-5.70

-0.27

Gross Profit (PBDT)

184.22

171.53

173.40

156.57

160.32

150.88

135.19

Depreciation

33.80

32.28

31.60

29.38

27.03

26.72

26.31

Profit Before Tax

43.38

37.96

33.15

36.66

45.84

34.35

31.47

Tax

10.80

7.81

5.20

8.21

10.12

6.11

3.84

Provisions and contingencies

0.00

Profit After Tax

32.58

30.15

27.95

28.44

35.73

28.24

27.63

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

32.58

30.15

27.95

28.44

35.73

28.24

27.63

Share in Profit of Associates

0.00

Minority Interest

0.00

Other related items

0.00

Consolidated Net Profit

32.58

30.15

27.95

28.44

35.73

28.24

27.63

Equity Capital

0.00

Face Value

0.0

Reserves

1,488.05

1,428.42

1,379.36

1,323.41

1,282.44

1,240.19

1,202.00

Earnings per share (EPS)

0.54

0.49

0.46

0.48

0.61

0.48

0.47

Diluted Earnings per share

0.54

0.49

0.46

0.48

0.61

0.48

0.47

Operating Profit Margin (Excl OI)

12.24%

14.33%

11.35%

10.73%

13.47%

12.9%

10.13%

Gross Profit Margin

20.21%

19.82%

18.26%

19.47%

21.59%

18.9%

17.87%

PAT Margin

8.53%

8.51%

7.88%

8.39%

10.58%

8.74%

8.55%

Public Share Holdings (%)

0.0%

Pledged Promotor Holding (%)

0.0%

Quarterly Analysis Highlights - QoQ

Net Sales

QoQ Growth in quarter ended Jun 2025 is 7.82% vs -0.08% in Mar 2025

Consolidate Net Profit

QoQ Growth in quarter ended Jun 2025 is 8.31% vs 7.89% in Mar 2025

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jun 2025 is -2.89% vs 15.60% in Mar 2025

Interest

QoQ Growth in quarter ended Jun 2025 is 3.03% vs -17.50% in Mar 2025

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025

Compare Quarterly Results Of Merit Medical Systems, Inc. With

Select Peers

Figures in Million

Consolidate Quarterly Results

Change(USD)

Change(%)

Net Sales

381.95

294.34

87.61

29.76%

Other Operating Income

0.00

Total Operating income

381.95

294.34

87.61

29.76%

Raw Material Cost

197.73

137.02

60.71

44.31%

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

0.00

Power Cost

0.00

Manufacturing Expenses

6.78

40.74

-33.96

-83.36%

Selling and Distribution Expenses

113.10

52.43

60.67

115.72%

Other Expenses

1.76

-4.07

5.83

143.24%

Total Expenditure (Excl Depreciation)

335.20

189.45

145.75

76.93%

Operating Profit (PBDIT) excl Other Income

46.76

104.90

-58.14

-55.42%

Other Income

2.20

0.54

1.66

307.41%

Operating Profit (PBDIT)

82.76

141.01

-58.25

-41.31%

Interest

6.78

40.74

-33.96

-83.36%

Exceptional Items

1.20

-45.80

47.00

102.62%

Gross Profit (PBDT)

184.22

157.32

26.90

17.10%

Depreciation

33.80

35.58

-1.78

-5.00%

Profit Before Tax

43.38

18.90

24.48

129.52%

Tax

10.80

10.94

-0.14

-1.28%

Provisions and contingencies

0.00

Profit After Tax

32.58

7.96

24.62

309.30%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

32.58

7.96

24.62

309.30%

Share in Profit of Associates

0.00

Minority Interest

0.00

Other related items

0.00

Consolidated Net Profit

32.58

7.96

24.62

309.30%

Equity Capital

0.00

Face Value

0.00

0.01

0.00

Reserves

1,488.05

511.28

976.77

191.04%

Earnings per share (EPS)

0.54

0.03

0.51

1,700.00%

Diluted Earnings per share

0.54

0.03

0.51

1,700.00%

Operating Profit Margin (Excl OI)

12.24%

35.64%

0.00

-23.40%

Gross Profit Margin

20.21%

18.51%

0.00

1.70%

PAT Margin

8.53%

2.70%

0.00

5.83%

Public Share Holdings (%)

0.00

0.00%

Pledged Promotor Holding (%)

0.00

0.00%

Quarterly - Net Sales

Net Sales 38.20 Million

in Jun 2025

Figures in Million

QoQ Growth in quarter ended Jun 2025 is 7.82% vs -0.08% in Mar 2025

YoY Growth in quarter ended Jun 2025 is 13.15% vs 5.70% in Jun 2024

Quarterly - Consolidate Net Profit

Consolidate Net Profit 3.26 Million

in Jun 2025

Figures in Million

QoQ Growth in quarter ended Jun 2025 is 8.31% vs 7.89% in Mar 2025

YoY Growth in quarter ended Jun 2025 is -8.68% vs 76.73% in Jun 2024

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 8.06 Million

in Jun 2025

Figures in Million

QoQ Growth in quarter ended Jun 2025 is -2.89% vs 15.60% in Mar 2025

YoY Growth in quarter ended Jun 2025 is 11.17% vs 29.93% in Jun 2024

Quarterly - Interest

Interest 0.68 Million

in Jun 2025

Figures in Million

QoQ Growth in quarter ended Jun 2025 is 3.03% vs -17.50% in Mar 2025

YoY Growth in quarter ended Jun 2025 is -19.05% vs 95.35% in Jun 2024

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 12.24%

in Jun 2025

Figures in %

QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025

YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024